You are here: Industry Insights > RNA

News List

Could COVID-19 vaccines be swallowed? EuropeanPharmaceuticalReview
February 10, 2022
New pre-clinical research demonstrates the potential of gastric autoinjectors to deliver mRNA in sufficient quantities for vaccination.
Poolbeg Pharma dives into nasally administered antivirals pharmatimes
January 17, 2022
If we have learnt anything from the last two years, it’s that virus protection is not to be sniffed at...
Roche awarded 2022 Drug Discovery of the Year for Evrysdi® EuropeanPharmaceuticalReview
December 07, 2021
The British Pharmacological Society has given the team of scientists who discovered and developed Evrysdi® (risdiplam) the Drug Discovery of the Year Award 2022.
Precision NanoSystems Announces Plans to Expand Global Headquarters contractpharma
August 12, 2021
Precision NanoSystems (PNI), a leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction.
Aragen, Skyhawk partner to develop small molecule therapeutics that correct RNA expression expresspharma
July 16, 2021
Through this collaboration, Aragen will provide Skyhawk with various discovery chemistry and biology service solutions.
Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics prnasia
July 13, 2021
Servier announced that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases.
Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures firstwordpharma
June 17, 2021
Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, with participation from Backed VC, Apollo Health Ventures, Selvedge, Hoxton .
RheaVita Closes EUR 2.5 million Series A Financing Co-Led by Novalis Biotech Acceleration and PMV firstwordpharma
June 04, 2021
RheaVita announced today that the company has closed a EUR 2.5 million Series A Financing. The round was co-led by Novalis Biotech Acceleration and Participatie Maatschappij Vlaanderen (PMV).
HDT Bio and Gennova dose healthy subjects in Covid-19 trial in India pharmaceutical-technology
May 06, 2021
HDT Bio and its development partner in India, Gennova Biopharmaceuticals, have started dosing healthy subjects with the Covid-19 vaccine in a Phase I/II trial in the country.
Evotec, Takeda Enter Multi-RNA Target Alliance contractpharma
March 23, 2021
Evotec SE has entered into a multi-RNA target alliance with Takeda Pharmaceutical Co. to discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.

Previous page 1 2 3 4 Next page